Briumvi
- BRIUMVI™(Ublituximab) is an intravenous injection treatment for relapsing forms of multiple sclerosis (MS) in adults.
- It is a CD20-directed cytolytic antibody that was first approved in the U.S. in 2022.
Screening[edit | edit source]
- Before using BRIUMVI, patients must be screened for hepatitis B virus and have a quantitative serum immunoglobulin screening.
- They should also pre-medicate with methylprednisolone and an antihistamine before each infusion.
Dosage[edit | edit source]
- The BRIUMVI dosage is 150 mg for the first infusion, 450 mg for the second infusion two weeks later, and 450 mg for subsequent infusions every 24 weeks.
- BRIUMVI should be diluted with 0.9% Sodium Chloride Injection before administration, and patients should be monitored closely during and after the first two infusions.
Contraindications[edit | edit source]
- BRIUMVI is contraindicated for those with active hepatitis B virus infection or a history of life-threatening infusion reactions to the treatment.
- Infusion reactions and infections, including serious and potentially fatal infections, may occur during treatment.
- Patients should avoid live-attenuated or live vaccines while on BRIUMVI and for some time after stopping it.
- The level of immunoglobulins should also be monitored, and BRIUMVI may be discontinued if serious opportunistic or recurrent infections occur.
- BRIUMVI can also cause fetal harm, so females of reproductive potential should be advised to use effective contraception during treatment and for at least 6 months after stopping it.
Side effects[edit | edit source]
Common adverse reactions include infusion reactions and upper respiratory tract infections.
Briumvi Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD